Skip to main content
Erschienen in: BMC Public Health 1/2015

Open Access 01.12.2015 | Research article

A cross sectional study on the motivators for Asian women to attend opportunistic mammography screening in a private hospital in Malaysia: the MyMammo study

verfasst von: Norhashimah Hassan, Weang Kee Ho, Shivaani Mariapun, Soo Hwang Teo

Erschienen in: BMC Public Health | Ausgabe 1/2015

Abstract

Background

To date, because of limited budgets and lower incidence of breast cancer, the majority of Asian countries do not have population-based screening programmes, but instead offer opportunistic screening. However, there have been few studies which have assessed the motivators for women attending such programmes and the appropriateness of the programmes in terms of targeting women at risk.

Methods

We conducted a prospective cross-sectional study of 1,619 women aged 40 to 74 years attending a subsidized opportunistic screening mammogram from October 2011 to October 2013 at a private hospital in Malaysia. Breast cancer risk was estimated using the Gail Model and two-step cluster analysis was used to examine the motivators of attending screening.

Results

Although Malaysia comprises 54.5 % Malay, 24.5 % Chinese and 7.3 % Indian, the majority of women in the MyMammo Study were Chinese (70.1 %) and 99.2 % had a <2 % ten-year risk of breast cancer. The most commonly cited barriers were the perception of not being at risk and fear of painful mammography. We found that highly educated women, cited doctors, family and friends as their main motivators. Of those with only secondary school education, their main motivators were doctors.

Conclusions

Taken together, our results suggest the women attending opportunistic mammography screening in Asia are at low risk of breast cancer and this poses challenges to cost-effective and equitable strategies for cancer control. We propose that to improve uptake of screening mammography, awareness programmes should target both doctors and members of the public.
Hinweise

Competing interests

The author(s) declare that they have no competing interests.

Authors’ contributions

NH and WKH carried out the statistical analysis and drafted the manuscript. SM recruited the patients and contributed to the design and coordination of the study. ST conceived the study, contributed to the design and coordination and drafted the manuscript. All authors read and approved the final manuscript.

Background

Breast cancer is the most common cancer in women and accounts for ~12.7 % of all cancer deaths in Asian women [1]. Although breast cancer incidence is lower in Asia compared to that in Western countries, it is now rising rapidly in Asian countries because of longer life expectancy and dramatic changes in parity and lifestyle [14]. The increasing burden of breast cancer in Asian countries is exacerbated by late presentation and limited access to therapies, resulting in poorer outcomes [57].
In high-income Asian countries with higher breast cancer incidence, such as Singapore, Korea and Japan, organized national mammographic screening is available, but uptake varies from 20 to 57 % [812]. In the other Asian countries, only opportunistic screening is available [13] and uptake is generally low, ranging from <1 % in Thailand [14], to ~7 % among rural Malaysian women [1517]. A number of reasons for poor uptake have been described in Singapore, Thailand, Malaysia and Iran, and these include cost of screening, lack of time, distance to screening facilities and fear of cancer [14, 1820].
Faced with limited budgets and an increasing incidence of breast cancer, the governments of Asian countries are facing difficult decisions on how to offer screening equitably and cost-effectively, and in particular, how to target limited resources to women at higher risk of developing breast cancer. However, there is paucity of data on the risk profile of Asian women attending opportunistic screening and limited data on how to motivate women to come forward for screening. In this study, we sought to describe the risk profile of women attending opportunistic screening at a private hospital in Malaysia, to examine the barriers and motivators of women attending screening, and to explore whether there are subgroups of healthy women with similar self-reported motivators for attending screening in Malaysia. Findings from these analyses may inform the utility of opportunistic mammography screening and further, the functional clustering may provide insight into how screening messages should be framed for more effective promotion of screening mammography in the future.

Methods

Study description

The Malaysian Mammography Study [MyMammo] is a subsidized opportunistic mammogram screening programme in a private tertiary hospital located in a suburban area in Malaysia. Screening was offered to women who did not have a personal history of breast cancer and who have not had a mammogram for at least one year prior to participating in the programme. Participants were recruited using flyers and posters at the hospital, and articles in the mainstream English, Chinese and Malay media. From October 2011 to October 2013, 1,619 women were enrolled into the study. Participants had a digital mammogram, donated a blood sample for research and completed a questionnaire of information in relation to demographic characteristics, anthropometric factors, menstrual and reproductive history, family history of cancer and, motivators and barriers for participating in the MyMammo study. Women were excluded if they were younger than 40 years old (n = 6), older than 74 years old (n = 4), previously diagnosed with other cancer (n = 23) or symptomatic (n = 133), leaving 1,453 in the final analysis. All women provided informed consent and this study was approved by the Sime Darby Medical Centre Independent Ethics Committee.

Estimation of breast cancer risk

The ten-year risk of breast cancer in all women were calculated at age of participation in MyMammo study using the publicly available Gail Model by including the following variables: age at menarche (<12 years, 12-13 years, ≥14 years), age at first live birth (<20 years, 20-24 years, 25-29 years, ≥30 years), history of previous breast surgery and the number of first degree relatives affected with breast cancer. Subjects were categorized as parous if they have had at least one full term pregnancy (live or still births) and the family history of breast cancer in a first degree relative included affected mothers and sisters. For calculations of population risk to breast cancer, the population risk of the Malaysian Chinese was based on that of the Chinese Asian-Americans while the population risk of Malaysian Malay and Indian women was based on that of other Asian-Americans [21].

Statistical analysis

SPSS software [Version 21] was used for all data analysis. The association between mammography history and baseline characteristics was investigated using Student’s t test and chi-square test for continuous and categorical variables respectively. A two-step cluster analysis was used to identify sub-groups of women with similar self-reported motivators for participating in the MyMammo Study. Women with previous breast biopsy (n = 136) were excluded, leaving a total of 1,317 women for analysis. Initial analysis included all variables and thereafter, variables without significant association with mammography history were removed sequentially (starting with the least significant variables). Models with acceptable cluster quality, smallest Schwarz’s Bayesian Criterion and significant differences between socio-demographic variables and motivators were selected. Differences between clusters were determined by Kruskal-wallis test for continuous variables and chi-square test for categorical variables.

Results

Study cohort

The MyMammo study is an opportunistic mammography screening programme established at a private hospital in the suburban area of Subang Jaya in Malaysia. The mean age was 50 years old, the majority of participants were Chinese [70.1 %], >90 % had secondary or tertiary education and 19 % were considered high income. The mean age of menarche was 13 years old and 84 % of women were parous, with a mean age of first live birth of 28 years old. Whilst 30 % of women had ever used oral contraceptives, less than 10 % had used hormone replacement therapy. Only 10 % of women report a family history of breast cancer and 9 % had previously had a breast biopsy. Twenty one percent of patients had previously had gynaecological surgery. Overall, the mean ten-year risk for women aged 40-79 was 0.77 %, ranging from 0.4 % to 14.4 %. The majority of women (n = 1453, 99.2 %) were estimated to have a <2 % risk of breast cancer, with only 0.8 % (n = 19) at 2 % risk (Fig. 1).
Women with previous mammogram were older (p < 0.001), tend to have higher socio-economic status (income p = 0.01, educational level p = 0.006), more likely to be menopausal (p < 0.001), have first live birth at an older age (p = 0.001), and more likely to have had hormone replacement therapy (p < 0.001) compared to women without previous mammogram. They also have higher proportion of positive family history of breast cancer (p < 0.001) and diabetic (p = 0.05). The remaining variables, namely ethnicity, age at menarche, smoking status and previous breast or gynaecological surgery, did not differ significantly between the two groups (Table 1).
Table 1
Malaysian Mammographic Study cohort description by mammography history
Variable
All women
Previous mammogram
First mammogram
P value
N = 1453
N = 744
N = 709
N
%
N
%
N
%
 
Demographics
       
Age1a[mean, sd]
50.0
7.0
53.0
7.0
48.0
7.0
<0.001
Ethnicity2a
       
Chinese
1018
70.1
530
71.2
488
68.8
0.194
Indian
223
15.4
117
15.7
106
  
Malay
160
 
69
9.3
91
12.8
 
Others
52
3.5
28
3.8
24
3.4
 
Education Level2
       
Primary
90
6.2
34
4.6
56
8.1
0.006
Secondary
728
50.1
366
49.9
362
52.3
 
Tertiary
608
41.8
334
45.5
274
39.6
 
Missing
27
 
10
 
17
  
Monthly Income (RM)2
       
Below 5 k
689
47.4
325
44.1
364
52.1
0.010
5 k to 10 k
470
32.4
260
35.3
210
  
Above 10 k
277
19.1
152
20.6
125
17.9
 
Missing
20
 
10
 
10
  
Hormonal
       
Endogenous
       
Age at menarche1a[mean, sd]
13.0
1.0
13.0
1.0
13.0
1.0
0.626
Missing
10
 
5
 
5
  
Menopausal status2
       
Pre/perimenopausal
783
53.9
299
40.2
484
68.6
<0.001
Post-menopausal
667
45.9
445
59.8
222
31.4
 
Missing
3
 
0
 
3
  
Parity2
       
Nulliparous
229
15.8
104
 
125
17.6
0.057
Parous
1224
84.2
640
 
584
82.4
 
Age at first live births1a[mean, sd]
28.0
5.0
28.0
5.0
27.0
5.0
0.001
Missing
230
 
105
 
125
  
Exogenous
       
Oral contraceptive usage status2
       
Never
1004
69.1
508
68.5
496
70.4
0.435
Ever used
443
30.5
234
31.5
209
29.6
 
Missing
6
 
2
 
4
  
Hormone replacement therapy
       
(HRT) status2
       
Never
1306
89.9
627
84.6
679
 
<0.001
Ever used
142
9.8
114
15.4
28
  
Missing
5
 
3
 
2
  
Medical history
       
Family history of breast cancer2a
       
No
1301
89.5
646
86.8
655
92.4
<0.001
Yes
152
10.5
98
13.2
54
7.6
 
Previous breast biopsy status2a
       
No
1305
89.8
676
91.5
629
89.6
0.224
Yes
136
9.4
63
8.5
73
10.4
 
Missing
12
 
5
 
7
  
Gynaecological surgery2
       
No
1143
78.7
578
79.7
565
79.7
0.352
Yes
310
21.3
166
22.3
144
20.3
 
Sterilisation
103
7.1
52
 
51
7.2
 
Oopherectomy
33
2.3
21
2.8
12
1.7
 
Hysterectomy
82
5.6
40
5.4
42
5.9
 
Total Hysterectomy/TAHBSO
69
4.8
37
 
32
4.5
 
Salpingectomy/salpingostomy
23
1.6
16
2.1
7
  
Body Mass Index (BMI)2
       
Underweight
48
3.3
16
 
32
4.5
0.030
Normal weight
812
55.9
425
57.1
387
  
Overweight
576
39.6
292
 
284
40.0
 
Missing
17
 
11
 
6
  
Diabetes status2
       
No
1335
91.9
673
91.1
662
93.8
0.050
Yes
110
7.6
66
8.9
44
6.2
 
Missing
8
 
5
 
3
  
Smoking status2
       
Never
1312
90.3
671
90.2
641
90.4
0.887
Ever smoked
141
9.7
73
9.8
68
9.6
 
aIndicates variables in the Gail Model
1Indicates continuous variable
2Indicates categorical variable
T-test was used for continuous variables and chi-square test for categorical variables
For 709 women (48.8 %) that cited the MyMammo Study as their first breast screening mammogram, 30 % (209) cited perception that they are not at risk, 20 % (139) cited fear of painful mammography, and 10 % (68) cited cost, as barriers of attending opportunistic screening.

Cluster analysis

Whilst the association analyses revealed the differences between women who have previously attended mammogram compared with those who had not, it did not reveal whether there were subgroups of healthy women with similar self-reported motivators for attending opportunistic screening in Malaysia. To do this, we conducted a cluster analysis to determine the characteristics of women presenting for opportunistic screening, starting first with a model containing all variables in Table 1, mammography history, age at first mammogram and motivators for attending screening, and sequentially excluding variables with the least association with mammography history (Table 2). We observed that the full model and Model two generated more than three clusters with poor separation. Models 1, 3, 4 and 6, and Models 5, 7 and 8 generated two and three clusters, respectively, with fair cluster quality and similar profiles. However, only the three-cluster models show a significant difference between motivators. Although there is a slight increase in BIC value after dropping parity and menopausal status from the analysis (comparing Model 5 with Model 8), the most parsimonious model was Model 8, as it contained the least variables and all variables in the model remained significantly different between the three clusters (Table 3).
Table 2
Summary for two-step cluster analysis
Model
Exclusiona
Number of Clusters
Schwarz's Bayesian Criterion (BIC)
Cluster quality
Full model
None
4
18827.990
Poor
Model 1
Exclude smoking status
2
18959.512
Fair
Model 2
Exclude age at menarche
5
16456.869
Poor
Model 3
Exclude oral contraceptive status
2
16212.759
Fair
Model 4
Exclude Gynaecology surgery status
2
15089.163
Fair
Model 5
Exclude ethnicity
3
12973.058
Fair
Model 6
Exclude parity status
2
13416.631
Fair
Model 7
Exclude menopausal status include parity
3
13372.869
Fair
Model 8
Exclude menopausal status
3
13453.375
Fair
aFull model consists of all variables in Table 1, mammography history, age at first screening and motivators for attending screening. Model 1 – Model 8: sequentially excluding variables with least association with mammography history
Table 3
Groups of asymptomatic healthy women attending Malaysian Mammographic study using the cluster analysis (N = 989)
 
Cluster 1
Cluster 2
Cluster 3
P-value
N = 451
N = 262
N = 276
 
Mean
sd
Mean
sd
Mean
sd
 
Age (years)a
52
6.0
45
5.0
51
8.0
<0.001
Age at first mammogram (years)a
44
6.0
45
5.0
50
7.0
<0.001
Age at first live birth (years)a
28
4.0
29
4.0
25
5.0
<0.001
 
N
%
N
%
N
%
 
Previous mammogram statusb
       
Never had a mammogram before
0
0.0
258
98.5
259
93.8
<0.001
Have had a mammogram before
451
100.0
4
1.5
17
6.2
 
Education levelb
       
Primary
9
2.0
0
0.0
54
19.6
<0.001
Secondary
222
49.2
66
25.2
219
79.3
 
Tertiary
220
48.8
196
74.8
3
1.1
 
Monthly income (RM)b
       
Below 5 k
180
39.9
36
13.7
236
85.5
<0.001
5 k to 10 k
164
36.4
127
48.5
37
13.4
 
Above 10 k
107
23.7
99
37.8
3
1.1
 
Family history of breast cancerb
       
None
392
86.9
237
90.5
261
94.6
0.009
1 affected individuals
54
12.0
25
9.5
14
5.1
 
2 affected individuals
5
1.1
0
0.0
1
0.4
 
HRT Usageb
       
Never
384
85.1
255
97.3
259
93.8
<0.001
Ever used
67
14.9
7
2.7
17
6.2
 
BMIb
       
Underweight
8
1.8
6
2.3
6
2.2
0.001
Normal weight
264
58.5
162
61.8
126
45.7
 
Overweight
179
39.7
94
35.9
144
52.2
 
Diabetes statusb
       
Unaffected
420
93.1
255
97.3
235
85.1
<0.001
Affected
31
6.9
7
2.7
41
14.9
 
Motivators for first mammogramb
       
Family & Friends
147
32.6
52
19.8
25
9.1
<0.001
Doctor
92
20.4
75
28.6
119
43.1
 
Myself
67
14.9
16
6.1
23
8.3
 
Public campaign
60
13.3
34
13.0
14
5.1
 
More than 1 motivators
37
8.2
23
8.8
17
6.2
 
No motivators
48
10.6
62
23.7
78
28.3
 
aIndicates continuous variable
bIndicates categorical variable
The first and largest cluster (N = 451) comprised older women (mean age 52 years), all of whom have had a mammogram previously (mean age of first mammogram 44 years). Notably, women in cluster 1 had the most significant family history of breast cancer (13.1 %) and the motivators for participating in opportunistic screening were varied (family and friends, doctors, themselves and public campaign).
Cluster 2 is the smallest group (N = 262) and consists of younger participants (mean age 45 years), the majority of whom have never had a mammogram (98.5 %). They are the most highly educated (75 % have attended college or university) and have the highest monthly income (38 % earned above RM10,000 per month). Women of this cluster had the smallest proportion of overweight (35.9 %) or diabetic women (2.7 %) and the lowest use of hormone replacement therapy (2.7 %). These women were motivated to attend opportunistic screening by their doctors, family or friends.
Cluster 3 (N = 276) consists of older women (mean age 51 years), the majority of whom have never had a mammogram previously (93.8 %). Women in this cluster had the lowest socio-economic status: 98.9 % were educated at primary or secondary level, and 85.5 % reported a monthly income of lower than RM5,000. Women from this cluster had their first live birth at the youngest age (25 years), had the least significant family history of breast cancer, and the largest proportion of diabetic (14.9 %) and overweight women (52.2 %). Significantly, amongst these older women from a lower socio-economic group, the majority were motivated by their doctors to attend opportunistic screening.
Although ethnicity was excluded from cluster analysis, further examination indicated that cluster 1 had the highest proportion among Indian women (70 out of 223, 31 %) and cluster 2 the highest among Malay women (76 out of 160, 44 %).

Discussion

The incidence of breast cancer is rising in most parts of Asia and Asian governments, particularly those from low and middle-income countries, face significant challenges in providing cost-effective and equitable screening for breast cancer. To date, the majority of low and middle-income Asian countries only offer opportunistic screening and the aspiration is that through health education and community health programmes, awareness and uptake of screening can help to ensure earlier presentation. In this study, we show that the majority of women attending opportunistic screening have an estimated <2 % risk of breast cancer in the next ten years, a threshold which is often considered where the benefits of screening outweigh the potential harms of over-diagnosis. This suggests that opportunistic screening in a private hospital in Malaysia does not target the women at high risk of breast cancer.
Previous studies using logistic regression have demonstrated a number of variables are associated with participation in mammography screening, but these studies provide limited information on how to target different groups of women [17, 18, 22]. In our study, we applied a different analytical method and suggest that functional clustering has provided insight into how screening messages should be framed for more effective promotion of mammography screening in the future. First, women with a higher risk of breast cancer on the basis of family history of breast cancer were more likely to attend screening at a younger age and they were motivated to participate in screening by various avenues. This suggests that health education focusing on the familial risk of breast cancer could be a strong motivator for Asian women to participate in screening but this approach has not hitherto been explored. Second, highly educated women could be motivated through a number of avenues including by their doctors, by family and friends or by public campaigns. Third, women in lower socio-economic classes were more likely to be motivated by their doctors to participate in screening. Taken together, this suggests that whilst highly educated women were accessible through public campaigns, women in lower socio-economic classes may not respond similarly to such campaigns. This is consistent with a systematic review of interventions to increase uptake of screening mammography among Asian women which suggests that media campaigns alone may be ineffective in increasing screening uptake [9]. In addition, our data suggests that doctors remain a significant avenue for educating women in lower socio-economic groups about screening and health education should specifically encourage primary care physicians to educate their clients about the potential benefits of screening. This is consistent with studies in Indian, Pakistani and Bangladeshi women in the UK where cultural awareness training for healthcare workers was found to increase mammography uptake [23].
The strength of the MyMammo study is the relatively large sample size and availability of data on breast cancer risk factors, which in turns enable the determination of the estimated risk of breast cancer. To date, reports on barriers and motivators among developing Asian countries have been limited to small cohorts, with limited information about breast cancer risk factors. However, the MyMammo study has a number of limitations. First, the study is conducted in a private hospital and study participants were asked to contribute a blood sample for research to determine genetic determinants of mammographic density. It is unknown whether these would have affected participation levels and the profiles of participating women. Second, as this is an opportunistic screening program, findings from this study cannot be extrapolated to the general population as it only represents a subset of women that came forward for screening.

Conclusions

The MyMammo Study has shown that the avenues for women to become aware of and be motivated to participate in opportunistic screening is different in high-income and low socio-economic women. Findings from this study may have implications on the approach of future health education and community awareness programmes in Malaysia and other Asian countries.

Acknowledgements

We thank Dr Yip Cheng Har and Maheswari Jaganathan for assistance with the recruitment of women in the study, and Sime Darby Ladies Professional Golf Association (LPGA) for funding the subsidized mammography programme. Sime Darby LPGA were not involved in the design, collection, analysis or interpretation of results.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
The Creative Commons Public Domain Dedication waiver (https://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Competing interests

The author(s) declare that they have no competing interests.

Authors’ contributions

NH and WKH carried out the statistical analysis and drafted the manuscript. SM recruited the patients and contributed to the design and coordination of the study. ST conceived the study, contributed to the design and coordination and drafted the manuscript. All authors read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.CrossRefPubMed Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.CrossRefPubMed
2.
Zurück zum Zitat Katanoda K, Matsuda T, Matsuda A, Shibata A, Nishino Y, Fujita M, et al. An updated report of the trends in cancer incidence and mortality in Japan. Jpn J Clin Oncol. 2013;43(5):492–507.CrossRefPubMed Katanoda K, Matsuda T, Matsuda A, Shibata A, Nishino Y, Fujita M, et al. An updated report of the trends in cancer incidence and mortality in Japan. Jpn J Clin Oncol. 2013;43(5):492–507.CrossRefPubMed
3.
Zurück zum Zitat Seow A, Duffy SW, McGee MA, Lee J, Lee HP. Breast cancer in Singapore: trends in incidence 1968-1992. Int J Epidemiol. 1996;25(1):40–5.CrossRefPubMed Seow A, Duffy SW, McGee MA, Lee J, Lee HP. Breast cancer in Singapore: trends in incidence 1968-1992. Int J Epidemiol. 1996;25(1):40–5.CrossRefPubMed
4.
Zurück zum Zitat Chia KS. Cancer survival in Singapore, 1993-1997. IARC Sci Publ. 2011;2(162):183–98. Chia KS. Cancer survival in Singapore, 1993-1997. IARC Sci Publ. 2011;2(162):183–98.
5.
Zurück zum Zitat Lan NH, Laohasiriwong W, Stewart JF. Survival probability and prognostic factors for breast cancer patients in Vietnam. Global Health Action. 2013;6:1–9.CrossRefPubMed Lan NH, Laohasiriwong W, Stewart JF. Survival probability and prognostic factors for breast cancer patients in Vietnam. Global Health Action. 2013;6:1–9.CrossRefPubMed
6.
Zurück zum Zitat Lee JH, Yim SH, Won YJ, Jung KW, Son BH, Lee HD, et al. Population-based breast cancer statistics in Korea during 1993-2002: incidence, mortality, and survival. J Korean Med Sci. 2007;22(Suppl):S11–16.CrossRefPubMedPubMedCentral Lee JH, Yim SH, Won YJ, Jung KW, Son BH, Lee HD, et al. Population-based breast cancer statistics in Korea during 1993-2002: incidence, mortality, and survival. J Korean Med Sci. 2007;22(Suppl):S11–16.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Leong SP, Shen ZZ, Liu TJ, Agarwal G, Tajima T, Paik NS, et al. Is breast cancer the same disease in Asian and Western countries? World J Surg. 2010;34(10):2308–24.CrossRefPubMedPubMedCentral Leong SP, Shen ZZ, Liu TJ, Agarwal G, Tajima T, Paik NS, et al. Is breast cancer the same disease in Asian and Western countries? World J Surg. 2010;34(10):2308–24.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Corbex M, Burton R, Sancho-Garnier H. Breast cancer early detection methods for low and middle income countries, a review of the evidence. Breast. 2012;21(4):428–34.CrossRefPubMed Corbex M, Burton R, Sancho-Garnier H. Breast cancer early detection methods for low and middle income countries, a review of the evidence. Breast. 2012;21(4):428–34.CrossRefPubMed
9.
Zurück zum Zitat Lu M, Moritz S, Lorenzetti D, Sykes L, Straus S, Quan H. A systematic review of interventions to increase breast and cervical cancer screening uptake among Asian women. BMC Public Health. 2012;12:413.CrossRefPubMedPubMedCentral Lu M, Moritz S, Lorenzetti D, Sykes L, Straus S, Quan H. A systematic review of interventions to increase breast and cervical cancer screening uptake among Asian women. BMC Public Health. 2012;12:413.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Sim HL, Seah M, Tan SM. Breast cancer knowledge and screening practices: a survey of 1,000 Asian women. Singapore Med J. 2009;50(2):132–8.PubMed Sim HL, Seah M, Tan SM. Breast cancer knowledge and screening practices: a survey of 1,000 Asian women. Singapore Med J. 2009;50(2):132–8.PubMed
11.
Zurück zum Zitat Lee K, Lim HT, Park SM. Factors associated with use of breast cancer screening services by women aged >or= 40 years in Korea: the third Korea National Health and Nutrition Examination Survey 2005 (KNHANES III). BMC Cancer. 2010;10:144.CrossRefPubMedPubMedCentral Lee K, Lim HT, Park SM. Factors associated with use of breast cancer screening services by women aged >or= 40 years in Korea: the third Korea National Health and Nutrition Examination Survey 2005 (KNHANES III). BMC Cancer. 2010;10:144.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Ishikawa Y, Hirai K, Saito H, Fukuyoshi J, Yonekura A, Harada K, et al. Cost-effectiveness of a tailored intervention designed to increase breast cancer screening among a non-adherent population: a randomized controlled trial. BMC Public Health. 2012;12:760.CrossRefPubMedPubMedCentral Ishikawa Y, Hirai K, Saito H, Fukuyoshi J, Yonekura A, Harada K, et al. Cost-effectiveness of a tailored intervention designed to increase breast cancer screening among a non-adherent population: a randomized controlled trial. BMC Public Health. 2012;12:760.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Yoo KB, Kwon JA, Cho E, Kang MH, Nam JM, Choi KS, et al. Is mammography for breast cancer screening cost-effective in both Western and asian countries?: results of a systematic review. Asian Pac J Cancer Prev. 2013;14(7):4141–9.CrossRefPubMed Yoo KB, Kwon JA, Cho E, Kang MH, Nam JM, Choi KS, et al. Is mammography for breast cancer screening cost-effective in both Western and asian countries?: results of a systematic review. Asian Pac J Cancer Prev. 2013;14(7):4141–9.CrossRefPubMed
14.
Zurück zum Zitat Amranand NN S, Nesterenko I, Rankova A, Tam K, Tangkijngamvong N. Promoting awareness and early detection of breast cancer in Thailand. 2010. Amranand NN S, Nesterenko I, Rankova A, Tam K, Tangkijngamvong N. Promoting awareness and early detection of breast cancer in Thailand. 2010.
15.
Zurück zum Zitat Rosmawati NH. The usage and knowledge of mammography among women in sub-urban area in Terengganu, Malaysia. Asian Pac J Cancer Prev. 2010;11(3):767–71.PubMed Rosmawati NH. The usage and knowledge of mammography among women in sub-urban area in Terengganu, Malaysia. Asian Pac J Cancer Prev. 2010;11(3):767–71.PubMed
16.
Zurück zum Zitat Dahlui M, Gan DE, Taib NA, Lim JN. Breast screening and health issues among rural females in Malaysia: how much do they know and practice? Prev Med. 2013;57(Suppl):S18–20.CrossRefPubMed Dahlui M, Gan DE, Taib NA, Lim JN. Breast screening and health issues among rural females in Malaysia: how much do they know and practice? Prev Med. 2013;57(Suppl):S18–20.CrossRefPubMed
17.
Zurück zum Zitat Parsa P, Kandiah M. Predictors of adherence to clinical breast examination and mammography screening among Malaysian women. Asian Pac J Cancer Prev. 2010;11(3):681–8.PubMed Parsa P, Kandiah M. Predictors of adherence to clinical breast examination and mammography screening among Malaysian women. Asian Pac J Cancer Prev. 2010;11(3):681–8.PubMed
18.
Zurück zum Zitat Teo CT, Yeo YW, Lee SC. Screening mammography behavior and barriers in Singaporean Asian women. Am J Health Behav. 2013;37(5):667–82.CrossRefPubMed Teo CT, Yeo YW, Lee SC. Screening mammography behavior and barriers in Singaporean Asian women. Am J Health Behav. 2013;37(5):667–82.CrossRefPubMed
19.
Zurück zum Zitat Al-Naggar RA, Bobryshev YV. Practice and barriers of mammography among Malaysian women in the general population. Asian Pac J Cancer Prev. 2012;13(8):3595–600.CrossRefPubMed Al-Naggar RA, Bobryshev YV. Practice and barriers of mammography among Malaysian women in the general population. Asian Pac J Cancer Prev. 2012;13(8):3595–600.CrossRefPubMed
20.
Zurück zum Zitat Lamyian M, Hydarnia A, Ahmadi F, Faghihzadeh S, Aguilar-Vafaie ME. Barriers to and factors facilitating breast cancer screening among Iranian women: a qualitative study. East Mediterr Health J. 2007;13(5):1160–9.PubMed Lamyian M, Hydarnia A, Ahmadi F, Faghihzadeh S, Aguilar-Vafaie ME. Barriers to and factors facilitating breast cancer screening among Iranian women: a qualitative study. East Mediterr Health J. 2007;13(5):1160–9.PubMed
21.
Zurück zum Zitat Matsuno RK, Costantino JP, Ziegler RG, Anderson GL, Li H, Pee D, et al. Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. J Natl Cancer Inst. 2011;103(12):951–61.CrossRefPubMedPubMedCentral Matsuno RK, Costantino JP, Ziegler RG, Anderson GL, Li H, Pee D, et al. Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. J Natl Cancer Inst. 2011;103(12):951–61.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Lerman C, Rimer B, Trock B, Balshem A, Engstrom PF. Factors associated with repeat adherence to breast cancer screening. Prev Med. 1990;19(3):279–90.CrossRefPubMed Lerman C, Rimer B, Trock B, Balshem A, Engstrom PF. Factors associated with repeat adherence to breast cancer screening. Prev Med. 1990;19(3):279–90.CrossRefPubMed
23.
Zurück zum Zitat Atri J, Falshaw M, Gregg R, Robson J, Omar RZ, Dixon S. Improving uptake of breast screening in multiethnic populations: a randomised controlled trial using practice reception staff to contact non-attenders. BMJ (Clinical research ed). 1997;315(7119):1356–9.CrossRef Atri J, Falshaw M, Gregg R, Robson J, Omar RZ, Dixon S. Improving uptake of breast screening in multiethnic populations: a randomised controlled trial using practice reception staff to contact non-attenders. BMJ (Clinical research ed). 1997;315(7119):1356–9.CrossRef
Metadaten
Titel
A cross sectional study on the motivators for Asian women to attend opportunistic mammography screening in a private hospital in Malaysia: the MyMammo study
verfasst von
Norhashimah Hassan
Weang Kee Ho
Shivaani Mariapun
Soo Hwang Teo
Publikationsdatum
01.12.2015
Verlag
BioMed Central
Erschienen in
BMC Public Health / Ausgabe 1/2015
Elektronische ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-015-1892-1

Weitere Artikel der Ausgabe 1/2015

BMC Public Health 1/2015 Zur Ausgabe